These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10070817)

  • 21. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
    Tanne D; Benderly M; Goldbourt U; Boyko V; Brunner D; Graff E; Reicher-Reiss H; Shotan A; Mandelzweig L; Behar S;
    Am J Med; 2001 Oct; 111(6):457-63. PubMed ID: 11690571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke.
    Koren-Morag N; Goldbourt U; Tanne D
    Am Heart J; 2008 Mar; 155(3):515-20. PubMed ID: 18294489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
    Wasilewski J; Osadnik T; Poloński L
    Kardiol Pol; 2006 Sep; 64(9):967-72; discussion 973-4. PubMed ID: 17054028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
    Barasch E; Benderly M; Graff E; Behar S; Reicher-Reiss H; Caspi A; Pelled B; Reisin L; Roguin N; Goldbourt U
    J Clin Epidemiol; 1995 Jun; 48(6):757-65. PubMed ID: 7769406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
    Stewart RA; White HD; Kirby AC; Heritier SR; Simes RJ; Nestel PJ; West MJ; Colquhoun DM; Tonkin AM;
    Circulation; 2005 Apr; 111(14):1756-62. PubMed ID: 15809366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
    Howard SC; Algra A; Rothwell PM;
    Cerebrovasc Dis; 2008; 25(1-2):136-43. PubMed ID: 18073467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
    Yokoyama M; Origasa H;
    Am Heart J; 2003 Oct; 146(4):613-20. PubMed ID: 14564313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a multifactorial prevention trial of coronary heart disease on the seasonal variation of the incidence of major cardiovascular events.
    Cucu F; Schioiu-Costache L; Damşa T; Steinbach M
    Rom J Intern Med; 1992; 30(3):175-85. PubMed ID: 1475595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ipact of bezafibrate treatment in patients with hyperfibrinogenemia and ST-elevation acute myocardial infarction: a randomized clinical trial.
    Madrid-Miller A; Moreno-Ruiz LA; Borrayo-Sánchez G; Almeida-Gutiérrez E; Martínez-Gómez DF; Jáuregui-Aguilar R
    Cir Cir; 2010; 78(3):229-37. PubMed ID: 20642906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
    Tanne D; Haim M; Boyko V; Goldbourt U; Reshef T; Matetzky S; Adler Y; Mekori YA; Behar S
    Stroke; 2002 Sep; 33(9):2182-6. PubMed ID: 12215584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
    Palamarchuk VI; Fedorishko SS
    Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary prevention is of significance for prognosis in coronary disease].
    de Faire U
    Lakartidningen; 1998 Oct; 95(42):4588-90, 4593-4. PubMed ID: 9814011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Dordević BS; Bosnjaković V; Baklaja-Jevremović R; Nastić D
    Acta Med Iugosl; 1970; 24(1):7-19. PubMed ID: 5201592
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
    Revutskiĭ EL; Palamarchuk VI; Vendt VP; Fedorishko SS
    Vrach Delo; 1979 Sep; (9):43-5. PubMed ID: 494607
    [No Abstract]   [Full Text] [Related]  

  • 38. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study.
    Haim M; Tanne D; Boyko V; Reshef T; Goldbourt U; Leor J; Mekori YA; Behar S
    J Am Coll Cardiol; 2002 Apr; 39(7):1133-8. PubMed ID: 11923036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [When will fibrinogen screening become available?].
    Ernst E
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group.
    Benderly M; Graff E; Reicher-Reiss H; Behar S; Brunner D; Goldbourt U
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):351-6. PubMed ID: 8630658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.